Antifungal activity of itraconazole compared with hydroxy-itraconazole in vitro

被引:50
|
作者
Odds, FC
Bossche, HV
机构
[1] Univ Aberdeen, Dept Mol & Cell Biol, Inst Med Sci, Aberdeen AB25 2ZD, Scotland
[2] Janssen Res Fdn, Dept Infect Dis, B-2340 Beerse, Belgium
关键词
D O I
10.1093/jac/45.3.371
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Microbroth dilution tests in vitro showed the same IC50 values for itraconazole and hydroxyitraconazole, within a mode a one dilution range of experimental error, for 90% of 1481 isolates of pathogenic fungi, representing 48 genera. Some 10-15% of Candida glabrata and Trichophyton mentagrophytes isolates were more susceptible to itraconazole than hydroxy-itraconazole. Replicate tests with bioassay marker strains of Candida kefyr and Candida albicans showed no susceptibility variations outside the mode +/- one dilution range. We conclude that few fungi differ substantially in their susceptibility to itraconazole and hydroxy-itraconazole.
引用
收藏
页码:371 / 373
页数:3
相关论文
共 50 条
  • [1] COMPARISON OF IN-VITRO ANTIFUNGAL ACTIVITY OF ITRACONAZOLE AND HYDROXY-ITRACONAZOLE BY COLORIMETRIC MTT ASSAY
    MIKAMI, Y
    SAKAMOTO, T
    YAZAWA, K
    GONOI, T
    UENO, Y
    HASEGAWA, S
    MYCOSES, 1994, 37 (1-2) : 27 - 33
  • [2] Variability of Hydroxy-Itraconazole in Relation to Itraconazole Bloodstream Concentrations
    Wiederhold, Nathan P.
    Schwartz, Ilan S.
    Patterson, Thomas F.
    Thompson, George R., III
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (04)
  • [3] Hydroxy-itraconazole pharmacokinetics is similar to that of itraconazole in immunocompromised patients receiving oral solution of itraconazole
    Mino, Yasuaki
    Naito, Takafumi
    Watanabe, Takayuki
    Yamada, Takahiro
    Yagi, Tatsuya
    Yamada, Hiroshi
    Kawakami, Junichi
    CLINICA CHIMICA ACTA, 2013, 415 : 128 - 132
  • [4] Population in vitro–in vivo pharmacokinetic model of first-pass metabolism: itraconazole and hydroxy-itraconazole
    Ahmad Y. Abuhelwa
    Stuart Mudge
    Richard N. Upton
    David J. R. Foster
    Journal of Pharmacokinetics and Pharmacodynamics, 2018, 45 : 181 - 197
  • [5] Population in vitro-in vivo pharmacokinetic model of first-pass metabolism: itraconazole and hydroxy-itraconazole
    Abuhelwa, Ahmad Y.
    Mudge, Stuart
    Upton, Richard N.
    Foster, David J. R.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 (02) : 181 - 197
  • [6] Does metabolite matter? Defining target itraconazole and hydroxy-itraconazole serum concentrations for blastomycosis
    Firkus, Danielle
    Abu Saleh, Omar M.
    Enzler, Mark J. J.
    Jannetto, Paul J.
    Mara, Kristin
    Vergidis, Paschalis
    Rivera, Christina G.
    Stevens, Ryan W.
    MYCOSES, 2023, 66 (05) : 412 - 419
  • [7] Repurposing antifungals: population pharmacokinetics of itraconazole and hydroxy-itraconazole following administration of a nanocrystal formulation
    Jansen, Anouk M. E.
    Ter Heine, Rob
    Donnelly, J. P.
    Blijlevens, Nicole
    Bruggemann, Roger J. M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 (05) : 1219 - 1224
  • [8] Simultaneous determination of voriconazole, posaconazole, itraconazole and hydroxy-itraconazole in human plasma using LCMS/MS
    Jenkins, Nicole
    Black, Marion
    Schneider, Hans G.
    CLINICAL BIOCHEMISTRY, 2018, 53 : 110 - 115
  • [9] DETERMINATION OF ITRACONAZOLE AND HYDROXY-ITRACONAZOLE IN SERA USING HIGH-PERFORMANCE-LIQUID CHROMATOGRAPHY AND A BIOASSAY
    HULSEWEDE, JW
    DERMOUMI, H
    ANSORG, R
    ZENTRALBLATT FUR BAKTERIOLOGIE-INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY VIROLOGY PARASITOLOGY AND INFECTIOUS DISEASES, 1995, 282 (04): : 457 - 464
  • [10] Column-switching chromatographic determination of itraconazole and its metabolite hydroxy-itraconazole in human serum
    Kubalec, P
    Brandsteterová, E
    PHARMAZIE, 2001, 56 (05): : 397 - 400